Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K.
Anadin Original.
| Pharmaceutical Form |
|---|
|
Tablet for oral administration. |
Active Ingredients:
Aspirin BP 325mg/tablet
Caffeine PhEur 15mg/tablet
For excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Acetylsalicylic acid |
Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs. |
|
| Caffeine |
Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. |
| List of Excipients |
|---|
|
Quinine Sulfate Ph Eur |
Cartons containing PVC/aluminium glassine paper blister strip 4, 6, 8, 12, 16, 24, 32 tablets.
Paper/Polyethylene strip 4, 8.
Polypropylene drum with CRC cap 24, 32.
Aluminium containers with approved polyethylene CRC Cap 16, 32.
Paper/Polyethylene laminated strip packs 4, 8.
GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K.
PL 44673/0203
31 August 1993
| Drug | Countries | |
|---|---|---|
| ANADIN | Ireland, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
